Last reviewed · How we verify

NCT03511547

Comparison of Arthroscopic Supraspinatus Tendon Tear Repair in Patients Over 60 Years With and Without Patch Augmentation.

Withdrawn NA Last updated 22 October 2020
What this trial tests

NA trial testing Pitch Patch in Rotator Cuff Tears. Withdrawn.

Timeline
1 January 2018
Primary endpoint
1 January 2021
1 January 2021

Quick facts

Lead sponsorSchulthess Klinik
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Start date1 January 2018
Primary completion1 January 2021
Estimated completion1 January 2021

Drugs / interventions tested

Conditions studied

Sponsor

Schulthess Klinik

Who can join

60 and older, any sex, with Rotator Cuff Tears. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to show that patch augmentation in rotatorcuff tear results in lower rate of recurrent tendon defects compared without patches.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Commercial Biomaterial-Based Products for Tendon Surgical Augmentation: A Scoping Review on Currently Available Medical Devices.
    Pluchino M, Vivarelli L, Giavaresi G, Dallari D, et al · · 2025 · cited 2× · PMID 40278238 · DOI 10.3390/jfb16040130

Verify or expand the search:

Other recruiting trials for Rotator Cuff Tears

Currently open trials in the same condition.

Other Schulthess Klinik trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03511547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing